BANK VONTOBEL/CALL/MEDTRONIC/82/0.1/20.12.24 Share Price

Warrant

DE000VD3SVN4

Market Closed - Boerse Frankfurt Warrants 11:32:39 05/07/2024 pm IST
0.26 EUR +8.33% Intraday chart for BANK VONTOBEL/CALL/MEDTRONIC/82/0.1/20.12.24
Current month-18.75%
1 month-46.94%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/24/05 0.26 +8.33%
04/24/04 0.24 -4.00%
03/24/03 0.25 +4.17%
02/24/02 0.24 -4.00%
01/24/01 0.25 -21.88%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 11:32 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SVN
ISINDE000VD3SVN4
Date issued 09/04/2024
Strike 82 $
Maturity 20/12/2024 (166 Days)
Parity 10 : 1
Emission price 0.71
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.82
Lowest since issue 0.234
Delta0.41x
Omega 11.05
Premium9.36x
Gearing27.02x
Moneyness 0.9465
Difference Strike 4.39 $
Difference Strike %+5.35%
Spread 0.01
Spread %3.70%
Theoretical value 0.2650
Implied Volatility 19.93 %
Total Loss Probability 63.92 %
Intrinsic value 0.000000
Present value 0.2650
Break even 84.87 €
Theta-0.01x
Vega0.02x
Rho0.01x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.61 USD
Average target price
94.02 USD
Spread / Average Target
+21.15%
Consensus